Abiopharma

News list

Director MURPHY MATTHEW J 🔴 sold 30.0K shares of Marvell Technology, Inc. (MRVL) at $98.70 ($3.0M) Transaction Date: Mar 26, 2026 | Filing ID: 021531

Full text

News bot March 26, 2026, 10:35 p.m.
🔍 MURPHY MATTHEW J (Director)

Company: Marvell Technology, Inc. (MRVL)

Report Date: 2026-03-26
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 30,000
Detailed Transactions and Holdings:
- Sold 30,000 shares of Common Stock at $98.7 per share (Direct)
  Date: 2026-03-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 310,106.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Sales were made pursuant to a 10b5-1 Plan dated December 16, 2025.
- F2: The price reported is a weighted average price. These shares were sold in multiple transactions at rounded prices ranging from $97.27 to $100.49, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.